UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 393

Sortiert nach

Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study

Annals of oncology, 2022-09, Vol.33 (9), p.929-938

2022

Link zum Volltext

Verfügbarkeit prüfen

The complex balance of PI3K inhibition

Annals of oncology, 2021-02, Vol.32 (2), p.127-128

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages

Annals of oncology, 2019-08, Vol.30 (8), p.1381-1392

2019

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibitor-based combinations: is dose escalation mandatory for phase I trials?

Annals of oncology, 2019-11, Vol.30 (11), p.1751-1759

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase 1b study of crenigacestat (LY3039478) in combination with gemcitabine and cisplatin or gemcitabine and carboplatin in patients with advanced or metastatic solid tumors

Cancer chemotherapy and pharmacology, 2022-10, Vol.90 (4), p.335-344

2022

Link zum Volltext

Verfügbarkeit prüfen

A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region

British journal of cancer, 2010-07, Vol.103 (2), p.165-170

2010

Link zum Volltext

Verfügbarkeit prüfen

Patients’ selection and trial matching in early-phase oncology clinical trials

Critical reviews in oncology/hematology, 2024-04, Vol.196, p.104307-104307, Article 104307

2024

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study

Annals of oncology, 2014-09, Vol.25 (9), p.1854-1860

2014

Link zum Volltext

Verfügbarkeit prüfen

Complete response to CSF1R inhibitor in a translocation variant of teno-synovial giant cell tumor without genomic alteration of the CSF1 gene

Annals of oncology, 2018-06, Vol.29 (6), p.1488-1489

2018

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group

British journal of cancer, 2013-08, Vol.109 (4), p.909-914

2013

Link zum Volltext

Verfügbarkeit prüfen

Health-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient endometrial cancer in the KEYNOTE-158 study

Gynecologic oncology, 2022-08, Vol.166 (2), p.245-253

2022

Link zum Volltext

Verfügbarkeit prüfen

Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database

Annals of oncology, 2014-06, Vol.25 (6), p.1222-1228

2014

Link zum Volltext

Verfügbarkeit prüfen

Healthcare worker protection against mpox contamination: position paper of the French Society for Hospital Hygiene

The Journal of hospital infection, 2023-10, Vol.140, p.156-164

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor

Scientific reports, 2019-10, Vol.9 (1), p.14551-8, Article 14551

2019

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab in Microsatellite Instability High or Mismatch Repair Deficient Cancers: Updated Analysis from the Phase 2 KEYNOTE-158 Study

Annals of oncology, 2022-06, Vol.33, p.P929-938

2022

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre study

The Journal of hospital infection, 2014-10, Vol.88 (2), p.103-108

2014

Link zum Volltext

Verfügbarkeit prüfen

GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study

Annals of oncology, 2013-11, Vol.24 (11), p.2922-2926

2013

Link zum Volltext

Verfügbarkeit prüfen

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

Annals of oncology, 2015-07, Vol.26 (7), p.1353-1362

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase I experience with rogaratinib in patients with head and neck cancer selected based on FGFR mRNA overexpression

Annals of oncology, 2018-10, Vol.29, p.viii377-viii377

2018

Link zum Volltext

Verfügbarkeit prüfen

Exogenous acquisition of Pseudomonas aeruginosa in intensive care units: a prospective multi-centre study (DYNAPYO study)

The Journal of hospital infection, 2020-01, Vol.104 (1), p.40-45

2020

Link zum Volltext

Verfügbarkeit prüfen

Outbreak of pulmonary Pseudomonas aeruginosa and Stenotrophomonas maltophilia infections related to contaminated bronchoscope suction valves, Lyon, France, 2014

Euro surveillance : bulletin européen sur les maladies transmissibles, 2016-07, Vol.21 (28), p.1

2016

Link zum Volltext

Verfügbarkeit prüfen

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours

British journal of cancer, 2013-11, Vol.109 (10), p.2574-2578

2013

Link zum Volltext

Verfügbarkeit prüfen

Imatinib-induced pigmentation of the hard palate

Annales de dermatologie et de vénéréologie, 2018-11, Vol.145 (11), p.723-724

2018

Link zum Volltext

Verfügbarkeit prüfen

Ramucirumab plus merestinib in previously treated metastatic colorectal cancer: safety, pharmacokinetic, and preliminary efficacy findings from a Phase 1 study

Annals of oncology, 2019-07, Vol.30, p.iv124-iv124

2019

Link zum Volltext

Verfügbarkeit prüfen

Rapid detection and evolutionary analysis of Legionella pneumophila serogroup 1 sequence type 47

Clinical microbiology and infection, 2017-04, Vol.23 (4), p.264.e1-264.e9

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 393

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(336)
Mit Volltextzugriff
(366)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(104)
Life Sciences & Biomedicine
(98)
Humans
(57)
Female
(45)
Male
(42)
Biological And Medical Sciences
(40)
Oncology
(39)
Animals
(33)
Life Sciences
(32)
Middle Aged
(31)
Fundamental And Applied Biological Sciences. Psychology
(29)
Adult
(26)
Insecta
(23)
Aged
(22)
Invertebrates
(22)
Entomology
(20)
Physiology. Development
(19)
Tumors
(19)
Biochemistry. Physiology. Immunology
(17)
Cell Biology
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study

The complex balance of PI3K inhibition

Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages

Immune checkpoint inhibitor-based combinations: is dose escalation mandatory for phase I trials?

A phase 1b study of crenigacestat (LY3039478) in combination with gemcitabine and cisplatin or gemcitabine and carboplatin in patients with advanced or metastatic solid tumors

A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region

Patients’ selection and trial matching in early-phase oncology clinical trials

Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study

Complete response to CSF1R inhibitor in a translocation variant of teno-synovial giant cell tumor without genomic alteration of the CSF1 gene

A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group

Health-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient endometrial cancer in the KEYNOTE-158 study

Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database

Healthcare worker protection against mpox contamination: position paper of the French Society for Hospital Hygiene

Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor

Pembrolizumab in Microsatellite Instability High or Mismatch Repair Deficient Cancers: Updated Analysis from the Phase 2 KEYNOTE-158 Study

Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre study

GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

Phase I experience with rogaratinib in patients with head and neck cancer selected based on FGFR mRNA overexpression

Exogenous acquisition of Pseudomonas aeruginosa in intensive care units: a prospective multi-centre study (DYNAPYO study)

Outbreak of pulmonary Pseudomonas aeruginosa and Stenotrophomonas maltophilia infections related to contaminated bronchoscope suction valves, Lyon, France, 2014

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours

Imatinib-induced pigmentation of the hard palate

Ramucirumab plus merestinib in previously treated metastatic colorectal cancer: safety, pharmacokinetic, and preliminary efficacy findings from a Phase 1 study

Rapid detection and evolutionary analysis of Legionella pneumophila serogroup 1 sequence type 47

Suchergebnisse filtern